Randomized Trial of Maternal Hyperimmune Globulin to Prevent Congenital Cytomegalovirus (CMV): 2 year outcomes
Conferences
Hughes, BL
Published in: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
January 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
EISSN
1097-6868
ISSN
0002-9378
Publication Date
January 2022
Volume
226
Issue
1
Start / End Page
S2 / S2
Related Subject Headings
- Obstetrics & Reproductive Medicine
- 3215 Reproductive medicine
Citation
APA
Chicago
ICMJE
MLA
NLM
Hughes, B. L. (2022). Randomized Trial of Maternal Hyperimmune Globulin to Prevent Congenital Cytomegalovirus (CMV): 2 year outcomes. In AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (Vol. 226, pp. S2–S2).
Hughes, Brenna L. “Randomized Trial of Maternal Hyperimmune Globulin to Prevent Congenital Cytomegalovirus (CMV): 2 year outcomes.” In AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 226:S2–S2, 2022.
Hughes BL. Randomized Trial of Maternal Hyperimmune Globulin to Prevent Congenital Cytomegalovirus (CMV): 2 year outcomes. In: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2022. p. S2–S2.
Hughes, Brenna L. “Randomized Trial of Maternal Hyperimmune Globulin to Prevent Congenital Cytomegalovirus (CMV): 2 year outcomes.” AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, vol. 226, no. 1, 2022, pp. S2–S2.
Hughes BL. Randomized Trial of Maternal Hyperimmune Globulin to Prevent Congenital Cytomegalovirus (CMV): 2 year outcomes. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2022. p. S2–S2.
Published In
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
EISSN
1097-6868
ISSN
0002-9378
Publication Date
January 2022
Volume
226
Issue
1
Start / End Page
S2 / S2
Related Subject Headings
- Obstetrics & Reproductive Medicine
- 3215 Reproductive medicine